Companies

TENAX THERAPEUTICS, INC. (TENX) SEC filings

CIK 0000034956 · Pharmaceutical Preparations (SIC 2834) · Nasdaq · incorporated in DE · fiscal year ends 12/31

Annual financials (from the company's own XBRL in its 10-K filings)

FY2025FY2024FY2023FY2022
Revenue (USD)00
Net income (USD)11.0 M-32.5 M
Diluted EPS (USD/shares)-1.34-31.04

Latest filings

FiledFormDescriptionPeriod
2026-10-214PRIMARY DOCUMENT2026-10-19
2026-10-15SCHEDULE 13G/ASCHEDULE 13G/A
2026-10-13SCHEDULE 13G/ASCHEDULE 13G/A
2026-10-09SCHEDULE 13G/ASCHEDULE 13G/A
2026-10-088-K8-K items 8.01,9.012026-10-08
2026-09-17442026-09-16
2026-09-154PRIMARY DOCUMENT2026-09-11
2026-09-15442026-09-11
2026-09-11SCHEDULE 13G/ASCHEDULE 13G/A
2026-09-098-K8-K items 7.01,9.012026-09-09
2026-09-084PRIMARY DOCUMENT2026-09-03
2026-09-08SCHEDULE 13GSCHEDULE 13G
2026-09-08SCHEDULE 13G/ASCHEDULE 13G/A
2026-09-024PRIMARY DOCUMENT2026-08-31
2026-08-27SCHEDULE 13GSCHEDULE 13G
2026-08-27SCHEDULE 13GSCHEDULE 13G
2026-08-244PRIMARY DOCUMENT2026-08-20
2026-08-243PRIMARY DOCUMENT2026-08-20
2026-08-18SCHEDULE 13GSCHEDULE 13G
2026-08-14SCHEDULE 13G/ASCHEDULE 13G/A
2026-08-14SCHEDULE 13G/ASCHEDULE 13G/A
2026-08-14SCHEDULE 13G/ASCHEDULE 13G/A
2026-08-14SCHEDULE 13G/ASCHEDULE 13G/A
2026-08-14SCHEDULE 13G/ASCHEDULE 13G/A
2026-08-14SCHEDULE 13G/ASCHEDULE 13G/A

Forms on file (last 1,000): 8-K 205, 4 170, 10-Q 87, 424B3 77, SCHEDULE 13G/A 48, 3 30, CORRESP 30, SC 13G/A 28. Source: SEC EDGAR, as filed; this page is public data and not investment advice.

For software and AI agents: the same data as JSON, per call, no account: GET https://store.agentexchange.work/gw/filings/company?ticker=TENX (0.002 USD), /gw/filings/filings?ticker=TENX&form=8-K, /gw/filings/facts?ticker=TENX&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txt

Updated from EDGAR within 30 minutes of a filing. Agent Exchange